Valiant Organics Limited carries a market capitalization of 7.78B, placing it among publicly traded companies globally. Its enterprise value stands at 8.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.78B |
| Enterprise Value | 8.17B |
Valiant Organics Limited currently has 28.02M shares outstanding.
| Shares Outstanding | 28.02M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valiant Organics Limited trades at a trailing price-to-earnings ratio of 17.04. The price-to-sales ratio is 0.77, and the price-to-book ratio stands at 20.21.
| PE Ratio | 17.04 |
| PS Ratio | 0.77 |
| PB Ratio | 20.21 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Valiant Organics Limited trades at an EV/EBITDA multiple of 16.84 and an EV/FCF ratio of 57.02. The EV/Sales ratio of 1.11 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.84 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.11 |
| EV / EBITDA | 16.84 |
| EV / EBIT | 16.84 |
| EV / FCF | 57.02 |
Valiant Organics Limited maintains a current ratio of 1.01, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.70, indicating elevated leverage, while an interest coverage ratio of 2.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.01 |
| Quick Ratio | 0.02 |
| Debt / Equity | 33.70 |
| Debt / EBITDA | 5.28 |
| Interest Coverage | 2.68 |
Valiant Organics Limited posts a return on equity of 11.37 and a return on invested capital of 3.87.
| Return on Equity (ROE) | 11.37 |
| Return on Assets (ROA) | 2.75 |
| Return on Invested Capital (ROIC) | 3.87 |
| Return on Capital Employed (ROCE) | 8.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.85 |
Over the trailing twelve months, Valiant Organics Limited has paid 87.06M in income taxes, reflecting an effective tax rate of 20.76.
| Income Tax | 87.06M |
| Effective Tax Rate | 20.76 |
Valiant Organics Limited's stock has declined approximately -33.44522% over the past 52 weeks. The 50-day moving average sits at 286.41, while the 200-day moving average is 272.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.44522% |
| 50-Day Moving Average | 286.41 |
| 200-Day Moving Average | 272.31 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Valiant Organics Limited generated 7.39B in revenue and converted that into 332.36M in net income, yielding earnings per share of 11.86. EBITDA reached 484.86M, while operating income came in at 484.86M.
| Revenue | 7.39B |
| Gross Profit | 3.01B |
| Operating Income | 484.86M |
| Pretax Income | 419.35M |
| Net Income | 332.36M |
| EBITDA | 484.86M |
| EBIT | 484.86M |
| Earnings Per Share (EPS) | 11.86 |
Valiant Organics Limited holds 57.46M in cash and equivalents against 2.56B in total debt, resulting in a net debt position of 2.51B. Total book value stands at 280.20M, with working capital of 19.78M providing operational flexibility.
| Cash & Cash Equivalents | 57.46M |
| Total Debt | 2.56B |
| Net Debt | 2.51B |
| Equity (Book Value) | 280.20M |
| Book Value Per Share | 10.00 |
| Working Capital | 19.78M |
Valiant Organics Limited operates with a gross margin of 40.80, reflecting its pricing power and cost economics. The operating margin of 6.56 and net profit margin of 4.50 provide insight into operational efficiency.
| Gross Margin | 40.80 |
| Operating Margin | 6.56 |
| Pretax Margin | 5.68 |
| Profit Margin | 4.50 |
| EBITDA Margin | 6.56 |
Valiant Organics Limited's most recent stock split took place on December 24, 2020 with a 1:2 split ratio.
| Last Split Date | 12/24/2020 |
| Split Ratio | 1:2 |
Valiant Organics Limited posts an Altman Z-Score of 1.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.46 |